Vascular and renal translational research group
- Number of publications
- 413
Publications
-
Bermudez-Lopez M; Perpiñan H; Amigo N; Castro E; Alonso N; Mauricio D; Fernandez E; Valdivielso JM
Advanced lipoprotein parameters could better explain atheromatosis in non-diabetic chronic kidney disease patients.
CLINICAL KIDNEY JOURNAL 14 2591-2599. .
-
Castelblanco E; Hernández M; Ortega E; Amigó N; Real J; Granado-Casas M; Miñambres I; Lopez C; Lecube A; Bermúdez-López M; Alonso N; Julve J; Mauricio D
Outstanding improvement of the advanced lipoprotein profile in subjects with new-onset type 1 diabetes mellitus after achieving optimal glycemic control.
DIABETES RESEARCH AND CLINICAL PRACTICE 182 109145-109145. .
-
Solache-Berrocal G; Rolle-Sóñora V; Martín-Fernández N; Cambray S; Valdivielso JM; Rodríguez I
CYP24A1 and KL polymorphisms are associated with the extent of vascular calcification but do not improve prediction of cardiovascular events.
NEPHROLOGY DIALYSIS TRANSPLANTATION 36 2076-2083. .
-
Del Carpio, J; Marco, MP; Martin, ML; Craver, L; Jatem, E; Gonzalez, J; Chang, P; Ibarz, M; Pico, S; Falcon, G; Canales, M; Huertas, E; Romero, I; Nieto, N; Segarra, A
External validation of the Madrid Acute Kidney Injury Prediction Score
CLINICAL KIDNEY JOURNAL 14 2377-2382. .
-
Caus M; Eritja À; Bozic M
Role of microRNAs in Obesity-Related Kidney Disease.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 22 -. .
-
Valdivielso JM; Balafa O; Ekart R; Ferro CJ; Mallamaci F; Mark PB; Rossignol P; Sarafidis P; Del Vecchio L; Ortiz A
Correction to: Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies.
DRUGS 81 1819-1819. .
-
Castelblanco E; Sarrias MR; Betriu À; Soldevila B; Barranco-Altirriba M; Franch-Nadal J; Valdivielso JM; Bermudez-Lopez M; Groop PH; Fernández E; Alonso N; Mauricio D
Circulating CD5L is associated with cardiovascular events and all-cause mortality in individuals with chronic kidney disease.
Aging-US 13 22690-22709. .
-
Alonso-Perez E; Forné C; Soro M; Valls M; Manganelli AG; Valdivielso JM
Health Care Costs in Patients with and without Secondary Hyperparathyroidism in Spain.
Advances in Therapy 38 5333-5344. .
-
Granado-Casas M; Martinez-Gonzalez D; Martínez-Alonso M; Dòria M; Alcubierre N; Valls J; Julve J; Verdú-Soriano J; Mauricio D
Psychometric Validation of the Cardiff Wound Impact Schedule Questionnaire in a Spanish Population with Diabetic Foot Ulcer.
Journal of Clinical Medicine 10 -. .
-
Benitez, I; Carratala, A; Moncusi-Moix, A; Gort-Paniello, C; Pinilla, L; Molinero, M; Gonzalez, J; Torres, G; Bernal, M; Pico, S; Almansa, R; Jorge, N; Ortega, A; Bustamante-Munguira, E; Gomez, JM; Gonzalez-Rivera, M; Micheloud, D; Ryan, P; Martinez, A; Tamayo, L; Aldecoa, C; Ferrer, R; Ceccato, A; Fernandez, L; Motos, A; Riera, J; Menendez, R; Garcia-Gasulla, D; Penuelas, O; Torres, A; Bermejo-Martin, JF; Barbe, F; Calvo, DD
Potential translation of plasma microRNA signatures in the risk stratification of COVID-19 patients admitted to the ICU
EUROPEAN RESPIRATORY JOURNAL 58 -. .
-
Mota-Zamorano S; Robles NR; González LM; Valdivielso JM; Lopez-Gomez J; Cancho B; García-Pino G; Gervasini G
Genetics Variants in the Epoxygenase Pathway of Arachidonic Metabolism Are Associated with Eicosanoids Levels and the Risk of Diabetic Nephropathy.
Journal of Clinical Medicine 10 -. .
-
Valdivielso, JM; Balafa, O; Ekart, R; Ferro, CJ; Mallamaci, F; Mark, PB; Rossignol, P; Sarafidis, P; del Vecchio, L; Ortiz, A
Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies
DRUGS 81 1467-1489. .